Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

2.

Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants.

Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, Raub TJ, Sawada GA, Palmer JR, Banitt LS, Tustin JS, Belonga KL, Ayer DE, Bundy GL.

Acta Neurochir Suppl. 1996;66:107-13. Review.

PMID:
8780807
3.
5.

Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage.

Zhang XS, Zhang X, Zhou ML, Zhou XM, Li N, Li W, Cong ZX, Sun Q, Zhuang Z, Wang CX, Shi JX.

J Neurosurg. 2014 Jul;121(1):42-54. doi: 10.3171/2014.2.JNS13730. Epub 2014 Apr 11.

PMID:
24724856
6.
7.
9.
11.

Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.

Suzuki H, Kanamaru K, Kuroki M, Sun H, Waga S, Miyazawa T.

Stroke. 1999 Feb;30(2):450-5; discussion 455-6.

12.

Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.

Hall ED, Andrus PK, Smith SL, Fleck TJ, Scherch HM, Lutzke BS, Sawada GA, Althaus JS, Vonvoigtlander PF, Padbury GE, Larson PG, Palmer JR, Bundy GL.

J Pharmacol Exp Ther. 1997 May;281(2):895-904.

13.

Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro.

Othberg A, Keep M, Brundin P, Lindvall O.

Exp Neurol. 1997 Oct;147(2):498-502. Erratum in: Exp Neurol 1998 Nov;154(1):260.

PMID:
9344573
14.
15.

Inhibition of lipid peroxidation in central nervous system trauma and ischemia.

Hall ED.

J Neurol Sci. 1995 Dec;134 Suppl:79-83. Review.

PMID:
8847548
16.

Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA.

J Neurosurg. 1995 May;82(5):786-90.

PMID:
7714603
17.

The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation.

Wang Y, Mathews WR, Guido DM, Jaeschke H.

J Pharmacol Exp Ther. 1996 May;277(2):714-20.

PMID:
8627550
18.
19.

Antivasospastic and brain-protective effects of a hydroxyl radical scavenger (AVS) after experimental subarachnoid hemorrhage.

Germanò A, Imperatore C, d'Avella D, Costa G, Tomasello F.

J Neurosurg. 1998 Jun;88(6):1075-81.

PMID:
9609303
20.

U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia.

Hall ED, Braughler JM, Yonkers PA, Smith SL, Linseman KL, Means ED, Scherch HM, Von Voigtlander PF, Lahti RA, Jacobsen EJ.

J Pharmacol Exp Ther. 1991 Aug;258(2):688-94.

PMID:
1865365

Supplemental Content

Support Center